Implications of genetic research on the role of the serotonin in depression: Emphasis on the serotonin type 1A receptor and the serotonin transporter

Psychopharmacology

Volumn 174, Issue 4, 2004, Pages 512-524

  Neumeister, Alexander ^a   Young, Theresa ^b   Stastny, Juergen ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

5 HT; Depression; Genes; Pathophysiology; Pharmacogenetics; Pharmacogenomics; Serotonin transporter; Serotonin type 1A receptor

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE; BETA CARBOMETHOXY 3BETA (4 IODOPHENYL)TROPANE I 123; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RADIOPHARMACEUTICAL AGENT; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL MODEL; DEPRESSION; DRUG RECEPTOR BINDING; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE INTERACTION; GENETIC POLYMORPHISM; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; NERVE TRACT; NEUROIMAGING; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

EID: 4344696091     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1950-3     Document Type: Review

References (143)

1. Abbott FV, Etienne P, Franklin KB, Morgan MJ, Sewitch MJ, Young SN (1992) Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108:60-66
2. Arias B, Arranz MJ, Gasto C et al. (2002) Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT (1A) receptor gene as putative risk factors in major depression. Mol Psychiatry 7:930-932; Erratum in: Mol Psychiatry 8:246
3. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976) "Serotonin depression" - a biochemical subgroup within the affective disorders? Science 191:478-480
4. Azmitia EC (1999) Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21:33S-45S
5. Azmitia EC, Whitaker-Azmitia PM (1991) Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 52 Suppl:4-16
6. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14:35-46
7. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
8. Bellivier F, Laplanche JL, Leboyer M et al. (1997) Serotonin transporter gene and manic depressive illness: an association study. Biol Psychiatry 41:750-752
9. Bellivier F, Szoke A, Henry C et al. (2000) Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry 48:319-322
10. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51:687-697
11. 11C]WAY-100635. Biol Psychiatry 54:890-895
12. 11C]WAY-100635. Mol Psychiatry 9:386-392
13. Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H (2000) Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry 5:193-195
14. 1A receptor knockout mice. J Neurochem 88:1373-1379
15. 3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline. J Psychiatr Neurosci 21:114-122
16. Carpenter LL, Anderson GM, Pelton GH et al. (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26-35
17. Carpenter LL, Tyrka AR, McDougle CJ et al. (2004) Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology 29:777-784
18. Caspi A, Sugden K, Moffitt TE et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389
19. Cloninger CR, Przybeck TR, Svrakic DM (1991) The tridimensional personality questionnaire: U.S. normative data. Psychol Rep 69:1047-1057
20. Collier DA, Stober G, Li T et al. (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453-460
21. Cook EH Jr, Courchesne R, Lord C et al. (1997) Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:247-250
22. Coppen A, Eccleston EG, Peet M (1973) Total and free tryptophan concentration in the plasma of depressive patients. Lancet 2:60-63
23. Courtet P, Buresi C, Abbar M et al. (2003) No association between non-violent suicidal behavior and the serotonin transporter promotor polymorphism. Am J Med Genet 1:72-76
24. Courtet P, Picot MC, Bellivier F et al. (2004) Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts. Biol Psychiatry 55:46-51
25. Cowen PJ, Charig EM (1987) Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry 44:958-966
26. Cowen PJ, Parry-Billings M, Newsholme EA (1989) Decreased plasma tryptophan levels in major depression. J Affect Disord 16:27-31
27. Czyrak A, Czepiel K, Mackowiak M, Chocyk A, Wedzony K (2003) Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res 989:42-51
28. Drevets WC, Frank E, Price JC et al. (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-1387
29. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH (1997) No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 2:224-226
30. Egede LE (2004) Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27:421-428
31. Erdmann J, Shimron-Abarbanell D, Cichon S et al. (1995) Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene. Am J Med Genet 60:393-399
32. Evans DL, Charney DS (2003) Mood disorders and medical illness: a major public health problem. Biol Psychiatry 54:177-180
33. Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF (1999) Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 4:93-96
34. 1A-mediated responses: effect on treatments that modify serotonergic neurotransmission. In: Whitaker-Azmitia PM, Peroutka SJ (eds) The neuropharmacology of serotonin. The New York Academy of Sciences, New York, pp 460-475
35. Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012
36. 11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse 47:123-133
37. Gold PW, Gabry KE, Yasuda MR, Chrousos GP (2002) Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin N Am 31:37-62, vi
38. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87
39. Greenberg BD, Li Q, Lucas FR et al. (2000) Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96:202-216
40. 1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur J Pharmacol 463:185-197
41. 1B receptor knockout mice in stress and anxiety paradigms. Behav Pharmacol 14:369-383
42. 1A receptor acts during development to establish normal anxiety-like behavior in the adult. Nature 416:396-400
43. Guttmacher AE, Collins FS (2002) Genomic medicine - a primer. N Engl J Med 347:1512-1520
44. Hariri AR, Mattay VS, Tessitore A et al. (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403
45. 1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Res 902:11-17
46. Healy D, Leonard BE (1987) Monoamine transport in depression: kinetics and dynamics. J Affect Disord 12:91-103
47. Heils A, Teufel A, Petri S et al. (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
48. Heils A, Mossner R, Lesch KP (1997) The human serotonin transporter gene polymorphism - basic research and clinical implications. J Neural Transm 104:1005-1014
49. Heim C, Nemeroff CB (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49:1023-1039
50. Heinz A, Jones DW, Mazzanti C et al. (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643-649
51. 1A receptor mutant mice. Proc Natl Acad Sci USA 95:15049-15054
52. Hendricks T, Francis N, Fyodorov D, Deneris ES (1999) The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J Neurosci 19:10348-10356
53. 1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144
54. Jorm AF, Henderson AS, Jacomb PA et al. (1998) An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 3:449-451
55. Kawanishi Y, Harada S, Tachikawa H et al. (1998) Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet 81:434-439
56. Kim DK, Lim SW, Lee S et al. (2000) Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11:215-219
57. Klaassen T, Riedel WJ, van Someren A, Deutz NE, Honig A, van Praag HM (1999) Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 46:489-497
58. Knobelman DA, Hen R, Blendy JA, Lucki I (2001a) Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. J Pharmacol Exp Ther 298:1092-1100
59. Knobelman DA, Hen R, Lucki I (2001b) Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. J Pharmacol Exp Ther 298:1083-1091
60. Knott VJ, Howson AL, Perugini M, Ravindran AV, Young SN (1999) The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects. Biol Psychiatry 46:229-238
61. Lemonde S, Turecki G, Bakish D et al. (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788-8799
62. Lesch KP, Balling U, Gross J et al. (1994) Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 95:157-162
63. Lesch KP, Bengel D, Heils A et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
64. Li T, Holmes C, Sham PC et al. (1997) Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 8:683-686
65. Little KY, McLaughlin DP, Zhang L et al. (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207-213
66. Mah EJ, Cunningham KA (1993) Electrophysiological studies of serotnergic (5-HT) modulation of glutamate-evoked activity in amygdala neurons. Soc Neurosci Abstr 19:1554
67. Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28:1562-1571
68. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D (1998) A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3:328-332
69. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098
70. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541-547
71. Manji HK, Quiroz JA, Sporn J et al. (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53:707-742
72. Mann JJ, McBride PA, Malone KM, DeMeo M, Keilp J (1995) Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 13:53-64
73. Mann JJ, Huang YY, Underwood MD et al. (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-738
74. Mazzanti CM, Lappalainen J, Long JC et al. (1998) Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 55:936-940
75. McDougle CJ, Epperson CN, Price LH, Gelernter J (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3:270-273
76. 1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol 266:255-261
77. 1A receptor mRNA by corticosterone. J Neuroendocrinol 7:653-657
78. Meijer OC, Van Oosten RV, De Kloet ER (1997) Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience 80:419-426
79. Meltzer HY, Maes M (1995) Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38:450-457
80. 2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 54:454-461
81. 1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology 55:444-450
82. Meyer JH, Wilson AA, Ginovart N et al. (2001) Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843-1849
83. Meyer JH, Wilson AA, Sagrati S et al. (2004) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 161:826-835
84. Minov C, Baghai TC, Schule C et al. (2001) Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303:119-122
85. Montgomery AJ, Bench CJ, Young AH et al. (2001) PET measurement of the influence of corticosteroids on serotonin-1A receptor number. Biol Psychiatry 50:668-676
86. Moreno FA, Gelenberg AJ, Heninger GR et al. (1999) Tryptophan depletion and depressive vulnerability. Biol Psychiatry 46:498-505
87. Murphy FC, Smith KA, Cowen PJ, Robbins TW, Sahakian BJ (2002) The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology 163:42-53
88. Murphy DL, Uhl GR, Holmes A et al. (2003) Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain Behav 2:350-364
89. Nakhai B, Nielsen DA, Linnoila M et al. (1995) Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28. Biochem Biophys Res Commun 210:530-536
90. Neumeister A (2003) Tryptophan depletion, serotonin, and depression: where do we stand? Psychopharmacol Bull 37:99-115
91. Neumeister A, Konstantinidis A, Stastny J et al. (2002) Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59:613-620
92. Neumeister A, Bain E, Nugent AC et al. (2004a) Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24:589-591
93. Neumeister A, Nugent AC, Waldeck T et al. (2004b) Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry (in press)
94. Oldman A, Walsh A, Salkovskis P, Fairburn CG, Cowen PJ (1995) Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot study. Psychol Med 25:995-1001
95. Oliveira JR, Gallindo RM, Maia LG et al. (1998) The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease. Mol Psychiatry 3:438-441
96. Ou XM, Jafar-Nejad H, Stoning JM, Meng JH, Lemonde S, Albert PR (2000) Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J Biol Chem 275:8161-8168
97. 1A receptor gene. J Neurosci 23:7415-7425
98. 1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6:101-110
99. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288-295
100. 1A receptors - behavioural and neurochemical pharmacology, vol 67. Ellis Horwood, Chichester, chapter 6
101. Parks CL, Shenk T (1996) The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 271:4417-4430
102. Parsons LH, Kerr TM, Tecott LH (2001) 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77:607-617
103. Pattij T, Hijzen TH, Groenink L et al. (2001) Stress-induced hyperhermia in the 5-HT(1A) receptor knockout mouse is normal. Biol Psychiatry 49:569-674
104. Pattij T, Groenink L, Hijzen TH et al. (2002a) Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. Neuropsychopharmacology 27:380-390
105. Pattij T, Groenink L, Ousting RS et al. (2002b) GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background. Eur J Pharmacol 447:67-74
106. Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97-122
107. Pollock BG, Ferrell RE, Mulsant BH et al. (2000) Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23:587-590
108. 1A sites and 5-HT transporter sites. Neurochem Res 19:311-315
109. Quintin P, Benkelfat C, Launay JM et al. (2001) Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder. Biol Psychiatry 50:184-190
110. Ramamoorthy S, Bauman AL, Moore KR et al. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546
111. Ramboz S, Oosting R, Amara DA et al. (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci 95:14476-14481
112. Rees M, Norton N, Jones I et al. (1997) Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 2:398-402
113. 2A receptors: increasing cGMP levels in rat frontal cortex. Neuropharmacology 45:1041-1049
114. Roses AD (2000) Idiosyncratic reactions to drugs: can medicine response profiles provide a dynamic drug surveillance system? Clin Chem Lab Med 38:815-818
115. Roses AD (2002) Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov 1:541-549
116. Rotondo A, Mazzanti C, Dell'Osso L et al. (2002) Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 159:23-29
117. Rudisch B, Nemeroff CB (2003) Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54:227-240
118. Sander T, Harms H, Lesch KP et al. (1997) Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res 21:1356-1359
119. 11C]WAY- 100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-180
120. Shioe K, Ichimiya T, Suhara T et al. (2003) No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48:184-188
121. Sibille E, Pavlides C, Benke D, Toth M (2000) Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 20:2758-2765
122. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 34:1029-1039
123. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508-511
124. Smith KA, Fairburn CG, Cowen PJ (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349:915-919
125. 1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707-715
126. Spurlock G, Buckland P, O'Donovan M, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33:433-440
127. 1A receptor gene. J Neurochem 72:2238-2247
128. Suhara T, Takano A, Sudo Y et al. (2003) High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry 60:386-391
129. Toth M (2003) 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur J Pharmacol 463:177-184
130. Verge D, Daval G, Marcinkiewicz M et al. (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:3474-3482
131. Voderholzer U, Hornyak M, Thiel B et al. (1998) Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18:112-124
132. 1B receptor knockout mice. Dev Psychobiol 42:194-205
133. 1A receptors in rat brain following antidepressant drug treatment. Synapse 4:347-352
134. Whitaker-Azmitia PM, Azmitia EC (1989) Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons. Brain Res 497:80-85
135. 1Areceptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 528:155-158
136. 1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse 14:201-205
137. Willeit M, Stastny J, Pirker W et al. (2001) No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry 50:8-12
138. World Health Organization (2001) Mental health: new understanding, new hope. World Health Organization, Geneva
139. 1A receptor gene. Psychiatr Genet 9:105-106
140. Yatham LN, Liddle PF, Shiah IS et al. (2001) Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study. Br J Psychiatry 178:448-453
141. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7:1115-1119
142. Zanardi R, Benedetti F, Di Bella D, Catalane M, Smeraldi E (2000) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 20:105-107
143. 1B receptors. Neuropsychopharmacology 21: S52-S60